The urine albumin‑creatinine ratio (urine ACR test) is a quick, inexpensive way to spot early kidney damage before symptoms appear. By comparing the amount of albumin (a protein) to creatinine (a waste product) in a single urine sample, doctors can detect albuminuria, monitor disease progression, and guide treatment for conditions like diabetes and hypertension.
A urine ACR test measures the concentration of albumin and creatinine in a spot urine sample and then calculates the ratio, usually expressed in milligrams of albumin per gram of creatinine (mg/g). This ratio corrects for variations in urine concentration, making it more reliable than a simple urine protein test. According to the National Kidney Foundation, the uACR is the preferred screening tool for detecting albuminuria in people at risk for chronic kidney disease (CKD).
Kidneys filter waste while keeping essential proteins like albumin in the bloodstream. When the glomeruli become damaged, albumin leaks into the urine, a condition called albuminuria or proteinuria. Detecting this leak early can:
For people with diabetes, the Kidney Fund notes that routine uACR screening is essential because diabetic kidney disease often begins with microalbuminuria.
The test requires a clean‑catch midstream urine sample, which can be collected at home or in a clinic. No fasting is needed, but the sample should be taken when the bladder is neither empty nor overly full. The laboratory measures albumin (mg) and creatinine (g) and reports the ratio. Some labs also provide a separate urine albumin test and a urine creatinine test, but the combined ratio is what clinicians use for interpretation.
Results are categorized by the National Kidney Foundation as follows:
| UACR (mg/g) | Albuminuria Category | What It Means |
|---|---|---|
| < 30 mg/g | Normal to Mildly Increased | Usually considered within the normal range. |
| 30–299 mg/g | Moderately Increased | May indicate early kidney damage or albuminuria. |
| ≥ 300 mg/g | Severely Increased | May indicate more significant kidney damage and needs medical evaluation. |
A result under 30 mg/g is considered normal, while values between 30 and 299 mg/g indicate microalbuminuria—a warning sign that kidney damage may be beginning. Values of 300 mg/g or higher reflect macroalbuminuria, which usually means more advanced kidney disease.
It’s important to remember that a single abnormal result does not automatically diagnose CKD. The NIDDK recommends repeating the urine ACR test one to two more times over a 3‑month period to confirm persistent albuminuria before labeling someone with chronic kidney disease.
Traditional urine protein tests measure total protein, which can be influenced by hydration status and muscle mass. The urine ACR test, by normalizing albumin to creatinine, provides a more stable estimate of kidney filtration function. This is why clinicians often prefer the uACR over a generic urine protein test when monitoring diabetic patients or those with hypertension.
For a deeper dive into related kidney tests, see our Kidney Tests Explained: Creatinine, eGFR, Urine ACR & Electrolytes.
When the urine ACR is above 30 mg/g, clinicians consider several possible causes:
Addressing reversible factors—like treating an infection or adjusting medication—can sometimes bring the ACR back into the normal range. Lifestyle changes (tight blood‑pressure control, low‑protein diet, smoking cessation) also help lower albuminuria over time.
eGFR estimates how well the kidneys filter blood, while uACR detects leakage of protein. Both are complementary: a normal eGFR with a high uACR signals early kidney damage, whereas a low eGFR with a normal uACR may indicate non‑proteinuric CKD. Combining these metrics improves risk stratification, as highlighted by the Labcorp ACR test description.
To ensure reliable results, follow these guidelines:
For more on how to prepare for lab tests, read our Protein in Urine Child: When to Seek Kidney Care.
If your first urine ACR result is abnormal, most clinicians will repeat the test after 2–4 weeks to confirm persistence. For patients with known CKD, the test may be ordered every 3–6 months, depending on disease stability and treatment changes. Diabetic patients are often advised to have a urine ACR at least once a year, as recommended by the American Diabetes Association.
Yes, in many cases. Tight glycemic control, blood‑pressure management (especially with ACE inhibitors or ARBs), and lifestyle modifications have been shown to reduce albuminuria. Studies cited by the Siemens Healthineers indicate that up to 30 % of patients can achieve a return to the normal range with appropriate therapy.
Ultimately, early detection through regular urine ACR screening empowers patients and providers to intervene before irreversible kidney damage occurs.
A urine ACR test measures the albumin‑to‑creatinine ratio in a spot urine sample, providing a snapshot of how much albumin is leaking into the urine relative to creatinine.
A high urine ACR (above 30 mg/g) indicates albuminuria, which can be an early sign of kidney damage, especially in diabetes or hypertension.
You provide a clean‑catch midstream urine sample; the lab quantifies albumin and creatinine and calculates the ratio, usually reported in mg/g.
The normal range is less than 30 mg/g; 30–299 mg/g is considered moderately increased (microalbuminuria), and 300 mg/g or higher is severely increased.
Diabetic patients should have a urine ACR test at least once a year, or more frequently if previous results were abnormal or kidney function is declining.
Yes—tight blood‑pressure control, ACE‑inhibitor or ARB therapy, and lifestyle changes can lower albuminuria and sometimes bring the ACR back to normal.
Understanding what a urine ACR test measures and how to interpret its results is essential for early kidney disease detection, especially for people with diabetes or hypertension. Schedule your screening, follow preparation tips, and work with your provider to monitor trends over time.